Fundraising FoxEpimAb Biotherapeutics
Shanghai, CN · 5 known investors
Find your way into EpimAb Biotherapeutics
Sign up to see every warm intro you have to EpimAb Biotherapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the EpimAb Biotherapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Epimab Biotherapeutics is a clinical-stage biopharmaceutical company specializing in the development of bispecific antibodies using proprietary technology platforms including FIT-Ig® and MAT-Fab. The company is advancing a pipeline of novel candidates targeting unmet clinical needs, with a focus on oncology applications.
Founders & leadership
Investors · 5
How we know: Decheng Capital's portfolio page · funding news · the VCSheet dataset · Not right? Tell us
How we know: ShangBay Capital LLC's portfolio page · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
Funding
SEC filings, press & company announcementsSource: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does EpimAb Biotherapeutics do?
- Epimab Biotherapeutics is a clinical-stage biopharmaceutical company specializing in the development of bispecific antibodies using proprietary technology platforms including FIT-Ig® and MAT-Fab. The company is advancing a pipeline of novel candidates targeting unmet clinical needs, with a focus on oncology applications.
- Who founded EpimAb Biotherapeutics?
- EpimAb Biotherapeutics was founded by Wu Chenbing.
- Who are EpimAb Biotherapeutics's investors?
- EpimAb Biotherapeutics's investors include Decheng Capital, ShangBay Capital LLC, TCG Labs, 3E Bioventures Capital, Sherpa Healthcare Partners.
- Where is EpimAb Biotherapeutics headquartered?
- EpimAb Biotherapeutics is headquartered in Shanghai, CN.